NDC 71335-1154 – Buprenorphine

Buprenorphine Hydrochloride 8 mg/1 · Tablet · Sublingual

Human Prescription Drug DEA schedule CIII

Product NDC71335-1154

Product details

Brand name
Buprenorphine
Generic name
Buprenorphine
Labeler
Bryant Ranch Prepack
Dosage form
Tablet
Route
Sublingual
Marketing category
ANDA · ANDA207276
Marketed since
October 25, 2017
Listing expires
December 31, 2027
Pharmacologic class
Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for Buprenorphine →

Package NDC codes (10)

Package NDCDescriptionSince
71335-1154-0120 TABLET in 1 BOTTLE (71335-1154-0)Apr 3, 2024
71335-1154-190 TABLET in 1 BOTTLE (71335-1154-1)Mar 15, 2019
71335-1154-260 TABLET in 1 BOTTLE (71335-1154-2)Mar 15, 2019
71335-1154-330 TABLET in 1 BOTTLE (71335-1154-3)Jul 22, 2019
71335-1154-420 TABLET in 1 BOTTLE (71335-1154-4)Apr 3, 2024
71335-1154-57 TABLET in 1 BOTTLE (71335-1154-5)Jan 16, 2020
71335-1154-628 TABLET in 1 BOTTLE (71335-1154-6)Jun 28, 2021
71335-1154-71 TABLET in 1 BOTTLE (71335-1154-7)Apr 3, 2024
71335-1154-812 TABLET in 1 BOTTLE (71335-1154-8)Apr 3, 2024
71335-1154-914 TABLET in 1 BOTTLE (71335-1154-9)Apr 3, 2024

Other Buprenorphine products